145 related articles for article (PubMed ID: 21688122)
1. The immunomodulatory properties of viable Lactobacillus salivarius ssp. salivarius CECT5713 are not restricted to the large intestine.
Arribas B; Garrido-Mesa N; Perán L; Camuesco D; Comalada M; Bailón E; Olivares M; Xaus J; Kruidenier L; Sanderson IR; Zarzuelo A; Rodríguez-Cabezas ME; Gálvez J
Eur J Nutr; 2012 Apr; 51(3):365-74. PubMed ID: 21688122
[TBL] [Abstract][Full Text] [Related]
2. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis.
Peran L; Camuesco D; Comalada M; Nieto A; Concha A; Diaz-Ropero MP; Olivares M; Xaus J; Zarzuelo A; Galvez J
World J Gastroenterol; 2005 Sep; 11(33):5185-92. PubMed ID: 16127750
[TBL] [Abstract][Full Text] [Related]
3. A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice.
Arribas B; Rodríguez-Cabezas ME; Camuesco D; Comalada M; Bailón E; Utrilla P; Nieto A; Concha A; Zarzuelo A; Gálvez J
Br J Pharmacol; 2009 Jul; 157(6):1024-33. PubMed ID: 19486007
[TBL] [Abstract][Full Text] [Related]
4. The viability of Lactobacillus fermentum CECT5716 is not essential to exert intestinal anti-inflammatory properties.
Rodríguez-Nogales A; Algieri F; Vezza T; Garrido-Mesa N; Olivares M; Comalada M; Riccardi C; Utrilla MP; Rodríguez-Cabezas ME; Galvez J
Food Funct; 2015 Apr; 6(4):1176-84. PubMed ID: 25700085
[TBL] [Abstract][Full Text] [Related]
5. Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis.
Sheil B; McCarthy J; O'Mahony L; Bennett MW; Ryan P; Fitzgibbon JJ; Kiely B; Collins JK; Shanahan F
Gut; 2004 May; 53(5):694-700. PubMed ID: 15082588
[TBL] [Abstract][Full Text] [Related]
6. Intestinal and immunological effects of daily oral administration of Lactobacillus salivarius CECT5713 to healthy adults.
Sierra S; Lara-Villoslada F; Sempere L; Olivares M; Boza J; Xaus J
Anaerobe; 2010 Jun; 16(3):195-200. PubMed ID: 20159049
[TBL] [Abstract][Full Text] [Related]
7. Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity.
Vinderola G; Perdigón G; Duarte J; Farnworth E; Matar C
Cytokine; 2006 Dec; 36(5-6):254-60. PubMed ID: 17363262
[TBL] [Abstract][Full Text] [Related]
8. Safety assessment of the human milk-isolated probiotic Lactobacillus salivarius CECT5713.
Lara-Villoslada F; Sierra S; Díaz-Ropero MP; Olivares M; Xaus J
J Dairy Sci; 2007 Aug; 90(8):3583-9. PubMed ID: 17638967
[TBL] [Abstract][Full Text] [Related]
9. Two Lactobacillus strains, isolated from breast milk, differently modulate the immune response.
Díaz-Ropero MP; Martín R; Sierra S; Lara-Villoslada F; Rodríguez JM; Xaus J; Olivares M
J Appl Microbiol; 2007 Feb; 102(2):337-43. PubMed ID: 17241338
[TBL] [Abstract][Full Text] [Related]
10. Lactobacilli reduce chemokine IL-8 production in response to TNF-α and Salmonella challenge of Caco-2 cells.
Ren DY; Li C; Qin YQ; Yin RL; Du SW; Ye F; Liu HF; Wang MP; Sun Y; Li X; Tian MY; Jin NY
Biomed Res Int; 2013; 2013():925219. PubMed ID: 24455739
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of immunomodulatory activity of two potential probiotic Lactobacillus strains by in vivo tests.
Ren D; Li C; Qin Y; Yin R; Du S; Liu H; Zhang Y; Wang C; Rong F; Jin N
Anaerobe; 2015 Oct; 35(Pt B):22-7. PubMed ID: 26143437
[TBL] [Abstract][Full Text] [Related]
12. In vitro immunomodulatory activity of Lactobacillus fermentum CECT5716 and Lactobacillus salivarius CECT5713: two probiotic strains isolated from human breast milk.
Pérez-Cano FJ; Dong H; Yaqoob P
Immunobiology; 2010 Dec; 215(12):996-1004. PubMed ID: 20219262
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the preventative effects exerted by Lactobacillus fermentum in an experimental model of septic shock induced in mice.
Arribas B; Rodríguez-Cabezas ME; Comalada M; Bailón E; Camuesco D; Olivares M; Xaus J; Zarzuelo A; Gálvez J
Br J Nutr; 2009 Jan; 101(1):51-8. PubMed ID: 18445307
[TBL] [Abstract][Full Text] [Related]
14. New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches.
Alard J; Peucelle V; Boutillier D; Breton J; Kuylle S; Pot B; Holowacz S; Grangette C
Benef Microbes; 2018 Feb; 9(2):317-331. PubMed ID: 29488412
[TBL] [Abstract][Full Text] [Related]
15. Probiotic properties of Lactobacillus salivarius and closely related Lactobacillus species.
Neville BA; O'Toole PW
Future Microbiol; 2010 May; 5(5):759-74. PubMed ID: 20441548
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory properties of probiotic bacteria on Salmonella-induced IL-8 synthesis in enterocyte-like Caco-2 cells.
Malago JJ; Tooten PC; Koninkx JF
Benef Microbes; 2010 Jun; 1(2):121-30. PubMed ID: 21840800
[TBL] [Abstract][Full Text] [Related]
17. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes.
Roselli M; Finamore A; Nuccitelli S; Carnevali P; Brigidi P; Vitali B; Nobili F; Rami R; Garaguso I; Mengheri E
Inflamm Bowel Dis; 2009 Oct; 15(10):1526-36. PubMed ID: 19504616
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide.
Macho Fernandez E; Valenti V; Rockel C; Hermann C; Pot B; Boneca IG; Grangette C
Gut; 2011 Aug; 60(8):1050-9. PubMed ID: 21471573
[TBL] [Abstract][Full Text] [Related]
19. Eradication of Helicobacter pylori infection by the probiotic strains Lactobacillus johnsonii MH-68 and L. salivarius ssp. salicinius AP-32.
Hsieh PS; Tsai YC; Chen YC; Teh SF; Ou CM; King VA
Helicobacter; 2012 Dec; 17(6):466-77. PubMed ID: 23067294
[TBL] [Abstract][Full Text] [Related]
20. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.
McCarthy J; O'Mahony L; O'Callaghan L; Sheil B; Vaughan EE; Fitzsimons N; Fitzgibbon J; O'Sullivan GC; Kiely B; Collins JK; Shanahan F
Gut; 2003 Jul; 52(7):975-80. PubMed ID: 12801954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
